Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
100.0%
-
Total 13F principal
-
$95,525,000
-
Principal change
-
-$27,445,000
-
Total reported market value
-
$107,136,000
-
Number of holders
-
21
-
Value change
-
-$26,165,489
-
Number of buys
-
4
-
Number of sells
-
8
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q4 2018
As of 31 Dec 2018,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$95,525,000
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., MANGROVE PARTNERS, CITADEL ADVISORS LLC, CVI Holdings, LLC, PERCEPTIVE ADVISORS LLC, Birch Grove Capital LP, Jefferies Group LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, GABELLI FUNDS LLC, and Bank of New York Mellon Corp.
This page lists
21
institutional bondholders reporting positions
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.